Onychomycosis
Authors:
- C. SeebacherCSC. Seebacher
- O. CornelyOCO. Cornely
- G. Ginter‐HanselmayerGGG. Ginter‐Hanselmayer
Abstract
Summary: The guideline on onychomycosis, as passed by the responsible German medical societies, is presented in the present study.Keywords
This publication has 26 references indexed in Scilit:
- Treatment options – development of consensus guidelinesJournal of the European Academy of Dermatology and Venereology, 2005
- Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosisJournal of Dermatological Treatment, 2005
- Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapyJournal of the European Academy of Dermatology and Venereology, 2004
- A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix regionBritish Journal of Dermatology, 2000
- Fluconazole 50 mg/day therapy in the management of chronic paronychiaJournal of Dermatological Treatment, 1999
- Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernailJournal of the American Academy of Dermatology, 1998
- An intermittent itraconazole 1‐week dosing regimen for the treatment of toenail onychomycosis in dermatological practiceMycoses, 1998
- Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infectionBMJ, 1995
- Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview)Clinical and Experimental Dermatology, 1992
- Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weeklyClinical and Experimental Dermatology, 1992